These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33295687)

  • 1. Linagliptin prevents left ventricular stiffening by reducing titin cleavage and hypophosphorylation.
    Cuijpers I; Papageorgiou AP; Carai P; Herwig M; Mügge A; Klein T; Hamdani N; Jones EAV; Heymans S
    J Cell Mol Med; 2021 Jan; 25(2):729-741. PubMed ID: 33295687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model.
    Hamdani N; Franssen C; Lourenço A; Falcão-Pires I; Fontoura D; Leite S; Plettig L; López B; Ottenheijm CA; Becher PM; González A; Tschöpe C; Díez J; Linke WA; Leite-Moreira AF; Paulus WJ
    Circ Heart Fail; 2013 Nov; 6(6):1239-49. PubMed ID: 24014826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes-Induced Cardiomyocyte Passive Stiffening Is Caused by Impaired Insulin-Dependent Titin Modification and Can Be Modulated by Neuregulin-1.
    Hopf AE; Andresen C; Kötter S; Isić M; Ulrich K; Sahin S; Bongardt S; Röll W; Drove F; Scheerer N; Vandekerckhove L; De Keulenaer GW; Hamdani N; Linke WA; Krüger M
    Circ Res; 2018 Jul; 123(3):342-355. PubMed ID: 29760016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium.
    Borbély A; Falcao-Pires I; van Heerebeek L; Hamdani N; Edes I; Gavina C; Leite-Moreira AF; Bronzwaer JG; Papp Z; van der Velden J; Stienen GJ; Paulus WJ
    Circ Res; 2009 Mar; 104(6):780-6. PubMed ID: 19179657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geranylgeranylacetone reduces cardiomyocyte stiffness and attenuates diastolic dysfunction in a rat model of cardiometabolic syndrome.
    Waddingham MT; Sequeira V; Kuster DWD; Dal Canto E; Handoko ML; de Man FS; da Silva Gonçalves Bós D; Ottenheijm CA; Shen S; van der Pijl RJ; van der Velden J; Paulus WJ; Eringa EC
    Physiol Rep; 2023 Nov; 11(22):e15788. PubMed ID: 37985159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased passive stiffness promotes diastolic dysfunction despite improved Ca2+ handling during left ventricular concentric hypertrophy.
    Røe ÅT; Aronsen JM; Skårdal K; Hamdani N; Linke WA; Danielsen HE; Sejersted OM; Sjaastad I; Louch WE
    Cardiovasc Res; 2017 Aug; 113(10):1161-1172. PubMed ID: 28472418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction.
    Hamdani N; Bishu KG; von Frieling-Salewsky M; Redfield MM; Linke WA
    Cardiovasc Res; 2013 Mar; 97(3):464-71. PubMed ID: 23213108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperphosphorylation of mouse cardiac titin contributes to transverse aortic constriction-induced diastolic dysfunction.
    Hudson B; Hidalgo C; Saripalli C; Granzier H
    Circ Res; 2011 Sep; 109(8):858-66. PubMed ID: 21835910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Titin and CK2α are New Intracellular Targets in Acute Insulin Application-Associated Benefits on Electrophysiological Parameters of Left Ventricular Cardiomyocytes From Insulin-Resistant Metabolic Syndrome Rats.
    Durak A; Bitirim CV; Turan B
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):487-501. PubMed ID: 32377826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy.
    Krüger M; Babicz K; von Frieling-Salewsky M; Linke WA
    J Mol Cell Cardiol; 2010 May; 48(5):910-6. PubMed ID: 20184888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice.
    Aroor AR; Habibi J; Kandikattu HK; Garro-Kacher M; Barron B; Chen D; Hayden MR; Whaley-Connell A; Bender SB; Klein T; Padilla J; Sowers JR; Chandrasekar B; DeMarco VG
    Cardiovasc Diabetol; 2017 May; 16(1):61. PubMed ID: 28476142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Titin isoform switch in ischemic human heart disease.
    Neagoe C; Kulke M; del Monte F; Gwathmey JK; de Tombe PP; Hajjar RJ; Linke WA
    Circulation; 2002 Sep; 106(11):1333-41. PubMed ID: 12221049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right ventricular diastolic impairment in patients with pulmonary arterial hypertension.
    Rain S; Handoko ML; Trip P; Gan CT; Westerhof N; Stienen GJ; Paulus WJ; Ottenheijm CA; Marcus JT; Dorfmüller P; Guignabert C; Humbert M; Macdonald P; Dos Remedios C; Postmus PE; Saripalli C; Hidalgo CG; Granzier HL; Vonk-Noordegraaf A; van der Velden J; de Man FS
    Circulation; 2013 Oct; 128(18):2016-25, 1-10. PubMed ID: 24056688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased myocardial stiffness due to cardiac titin isoform switching in a mouse model of volume overload limits eccentric remodeling.
    Hutchinson KR; Saripalli C; Chung CS; Granzier H
    J Mol Cell Cardiol; 2015 Feb; 79():104-14. PubMed ID: 25450617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of titin modulates passive stiffness of cardiac muscle in a titin isoform-dependent manner.
    Fukuda N; Wu Y; Nair P; Granzier HL
    J Gen Physiol; 2005 Mar; 125(3):257-71. PubMed ID: 15738048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness.
    Michel K; Herwig M; Werner F; Špiranec Spes K; Abeßer M; Schuh K; Dabral S; Mügge A; Baba HA; Skryabin BV; Hamdani N; Kuhn M
    JCI Insight; 2020 Nov; 5(22):. PubMed ID: 33055420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs.
    Krüger M; Kötter S; Grützner A; Lang P; Andresen C; Redfield MM; Butt E; dos Remedios CG; Linke WA
    Circ Res; 2009 Jan; 104(1):87-94. PubMed ID: 19023132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy.
    Nagueh SF; Shah G; Wu Y; Torre-Amione G; King NM; Lahmers S; Witt CC; Becker K; Labeit S; Granzier HL
    Circulation; 2004 Jul; 110(2):155-62. PubMed ID: 15238456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental changes in passive stiffness and myofilament Ca2+ sensitivity due to titin and troponin-I isoform switching are not critically triggered by birth.
    Krüger M; Kohl T; Linke WA
    Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H496-506. PubMed ID: 16679402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Titin-Based Cardiac Myocyte Stiffening Contributes to Early Adaptive Ventricular Remodeling After Myocardial Infarction.
    Kötter S; Kazmierowska M; Andresen C; Bottermann K; Grandoch M; Gorressen S; Heinen A; Moll JM; Scheller J; Gödecke A; Fischer JW; Schmitt JP; Krüger M
    Circ Res; 2016 Oct; 119(9):1017-1029. PubMed ID: 27650557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.